CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) Stock Income Statement
TSX-V:CYTO - TSX Venture Exchange - CA2328211081 - Common Stock - Currency: CAD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 5.68M | 5.04M | 3.66M | 3.20M | |||
| Research and Development | 22.00K | 441.90K | 442.60K | 424.80K | |||
| Selling, General, and Administrative Expenses | 4.69M | 4.08M | 3.44M | 2.94M | |||
| Operating Income | -5.68M | -5.04M | -3.66M | -3.20M | |||
| Interest Income/Expense | 24.60K | -30.50K | -20.10K | -30.50K | |||
| Other Income/Expense | 449.00K | 445.10K | N/A | N/A | |||
| Non Recurring Items | -2.70M | -10.90K | N/A | N/A | |||
| Income Before Taxes | -7.91M | -4.64M | -3.68M | -3.24M | |||
| Net Income | -7.91M | -4.64M | -3.68M | -3.24M | |||
| EBITDA | -4.98M | -4.53M | -3.30M | -2.91M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -0.28 | -0.55 | -0.44 | -0.38 | |||
| Statistics | |||||||
All data in CAD